English Name: Recombinant Human Papillomavirus Bivalent (Type 16, 18) Vaccine (Escherichia coli)

Dosage Form: Liquid for injection

Specification: 0.5 ml/vial, each dose contains: 40μg recombinant HPV 16 L1 protein and 20μg HPV 18 L1 protein

Indication: Indicated for women aged 9-45 years to prevent Cervical cancer, Cervical intraepithelial neoplasia Grade 1, Grade 2 or 3 (CIN2/3), adenocarcinoma in-situ (AIS) and persistent infections of HPV types 16 and/or 18.

Administration: Intramuscular injection

Shelf Life: 36 months